Efficacy News and Research

RSS
Sangart reports positive data from MP4OX Phase IIa study in trauma patients

Sangart reports positive data from MP4OX Phase IIa study in trauma patients

ESC issues revised practice guidelines for management of AF

ESC issues revised practice guidelines for management of AF

Study shows DERMACYTE Oxygen Concentrate improves skin appearance

Study shows DERMACYTE Oxygen Concentrate improves skin appearance

Pathology experts to evaluate medical, surgical breast cancer treatment at World Senologyc Congress

Pathology experts to evaluate medical, surgical breast cancer treatment at World Senologyc Congress

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list   for depression treatment

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list for depression treatment

Findings suggest sustainable school-base prevention program for youth at risk for substance abuse

Findings suggest sustainable school-base prevention program for youth at risk for substance abuse

Standard dose of UFH optimal for treatment of PCI patients on fondaparinux: Study

Standard dose of UFH optimal for treatment of PCI patients on fondaparinux: Study

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

Data monitoring committee recommends early termination following impressive results of AVERROES study

Data monitoring committee recommends early termination following impressive results of AVERROES study

Phase 3 EINSTEIN-DVT clinical trial data can transform deep vein thrombosis treatment

Phase 3 EINSTEIN-DVT clinical trial data can transform deep vein thrombosis treatment

Study: IV ibuprofen decreases pain, morphine use in pre and post-operative orthopedic surgery patients

Study: IV ibuprofen decreases pain, morphine use in pre and post-operative orthopedic surgery patients

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

Amsterdam Molecular first half 2010 net loss in line with last year

Amsterdam Molecular first half 2010 net loss in line with last year

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Roche's MabThera continues to dwarf recently launched monoclonal antibodies: Report

Roche's MabThera continues to dwarf recently launched monoclonal antibodies: Report

FDA grants Priority Review status to Alimera Sciences' Iluvien for diabetic macular edema

FDA grants Priority Review status to Alimera Sciences' Iluvien for diabetic macular edema

Phase 2 INNOVATE PCI trial results for elinogrel presented

Phase 2 INNOVATE PCI trial results for elinogrel presented

Smoked cannabis relieves chronic neuropathic pain

Smoked cannabis relieves chronic neuropathic pain

BDSI's Phase 2 study results of BEMA Buprenorphine selected for presentation at Pain Week 2010

BDSI's Phase 2 study results of BEMA Buprenorphine selected for presentation at Pain Week 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.